tiprankstipranks
Analyst Profile
Followed by 39 other investors
.
Tiago Fauth

Tiago Fauth

Credit Suisse
Wall Street Analyst
Ranked #7,785 out of 8,054 Analysts on TipRanks (#20,809 out of 21,594 overall experts)

Success Rate

35%
30 out of 85 Profitable Transactions

Average Return

-13.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
If you copied Tiago Fauth's ratings since 2020 and opened each position for the duration of 1 Year:
35.29% of your transactions would have been profitable with an average return of -13.1%

Stock Rating Distribution

133Ratings
66.17% Buy
29.32% Hold
4.51% Sell
Distribution of Tiago Fauth's ratings

Additional Information

Main Sector:General
Geo Coverage:
United StatesUS Market
United KingdomUK Market

Best Rating

Stock:
IVERIC bio Inc
(ISEE)
Rating Type:Buy
Dates:Mar 03, 2021 - Mar 03, 2022
Gain:141.00%
The most profitable rating made by Tiago Fauth

Tiago Fauth's Stock Coverage

Company Name
Date
Position
Action
Price Target
Success Rate
Avg Return
No. of Ratings
PTLA
Portola Pharma
Feb 26, 2020
Hold
Reiterated
0.00%
3
arGEN X
Oct 22, 2020
Hold
Reiterated
€240.00
(-36.00% Downside)
0.00%
1
Intercept Pharma
Nov 10, 2020
Hold
Reiterated
$42.00
(132.43% Upside)
0%
-61.00%
3
Forma Therapeutics Holdings
Mar 30, 2021
Buy
Reiterated
$62.00
(442.91% Upside)
0%
-58.00%
3
XLRN
Acceleron Pharma
Apr 26, 2021
Buy
Initiated
100%
+41.10%
1
ALXN
Alexion Pharmaceuticals
Apr 26, 2021
Hold
Initiated
0.00%
1
Amgen
Apr 28, 2021
Buy
Reiterated
$259.00
(2.31% Upside)
100%
+0.90%
2
VectivBio Holding
May 04, 2021
Buy
Initiated
$24.00
(329.72% Upside)
0%
-69.70%
1
Immunovant
Aug 02, 2021
Sell
Downgraded
$7.00
(34.62% Upside)
33%
-11.00%
7
Galecto
Aug 06, 2021
Buy
Reiterated
$7.00
(225.58% Upside)
0%
-62.05%
2
List of latest recommendations made by Tiago Fauth. Click to expand and see Tiago Fauth's performance on a particular stock
Disclaimer: TipRanks collects ratings and price targets of analysts by scanning publicly available reports on financial websites and by receiving reports directly from the analysts or from our users. The information displayed and the Analyst Profile statistics might not be accurate, complete, or up to date. The analyst ratings provided are entirely at the sole responsibility of the of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings or opinions expressed on the site.
Are We Missing a Rating?
Send us the equity research you are getting and become a Power User
Learn More